Novo Nordisk A/S (Novo Nordisk) has appointed Andy Ajello as vice president (VP) for national diabetes sales, managed care and government accounts. In his new capacity, he will lead the company's 2,000-person field sales organization. Ajello joined Novo Nordisk in 2001 where he helped to launch NovoLog. Ajello will report directly to Jerzy Gruhn, president of Novo Nordisk's North American affiliate. Ajello was most recently the associate vice president of Diabetes Sales for the eastern area.
“In his eight years at Novo Nordisk, Andy has developed an impressive track record for building high performing field sales teams,” said Jerzy Gruhn, president of Novo Nordisk Inc. “His focus on cross-functional collaboration, quick decision-making and strategic execution will help us continue our growth and ultimately realize our ambition of changing diabetes.”
Ajello has been recognized and awarded at Novo Nordisk for achievements in sales leadership, training, and marketing, including being named as the Novo Nordisk international sales manager of the Year in 2007. Ajello’s unique style and insights into team development and management were featured in a Wall Street Journal article in 2008. Prior to Novo Nordisk, Ajello held a 10-year tenure at GlaxoSmithKline.
Ajello received a Bachelor’s degree in economics from Susquehanna University.